Chemin, Isabelle

Publishing since 1996 (Senior)

Has published 28 publications in 15 years

Number of publications published per year by Chemin, Isabelle. (Source : PubMed)

Distribution of publications types for Chemin, Isabelle. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Lucifora J, Vincent IE, Berthillon P, Dupinay T, Michelet M, Protzer U, Zoulim F, Durantel D, Trepo C, Chemin I. Hepatitis B virus replication in primary macaque hepatocytes: Crossing the species barrier toward a new small primate model.  Hepatology  2010  
•  Chemin I. Evaluation of a hepatitis B vaccination program in Taiwan: impact on hepatocellular carcinoma development.  Future oncology (London, England)  2010;6;1  
•  Chemin I, Zoulim F. Hepatitis B virus induced hepatocellular carcinoma.  Cancer Lett.  2009;286;1  
•  Pujol FH, Navas MC, Hainaut P, Chemin I. Worldwide genetic diversity of HBV genotypes and risk of hepatocellular carcinoma.  Cancer Lett.  2009;286;1  
•  Plymoth A, Chemin I, Boffetta P, Hainaut P. Editorial foreword special issue "hepatocellular carcinoma--a worldwide translational approach".  Cancer Lett.  2009;286;1  
•  Chemin I, Guillaud O, Queyron PC, Trépo C. Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection.  J. Hepatol.  2009;51;4  
•  Vincent IE, Lucifora J, Durantel D, Hantz O, Chemin I, Zoulim F, Trepo C. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.  Antivir. Ther. (Lond.)  2009;14;1  
•  Almeida D, Tavares-Neto J, Trepo C, Almeida A, Mello C, Chemin I, Paraná R. Occult B infection in the Brazilian northeastern region: a preliminary report.  Braz J Infect Dis  2008;12;4  
•  Bengochea A, de Souza MM, Lefrançois L, Le Roux E, Galy O, Chemin I, Kim M, Wands JR, Trepo C, Hainaut P, Scoazec JY, Vitvitski L, Merle P. Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma.  Br. J. Cancer  2008;99;1  
•  Mrani S, Chemin I, Menouar K, Guillaud O, Pradat P, Borghi G, Trabaud MA, Chevallier P, Chevallier M, Zoulim F, Trépo C. Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C.  J. Med. Virol.  2007;79;8  

[ See timeline ] [ See all publications ]